Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

LiveKidney is a clinical-stage cell therapy company that develops proprietary, pharmaceutical grade, hydrogel-based formulations of umbilical cord Mesenchymal Stromal Cells (UC-MSCs) to treat advanced kidney disease and prevent its progression towards kidney failure. The company's products allow the continuous release of bioactive compounds from the UC-MSCs to the kidneys via unique routes of administration, triggering anti-in...
LiveKidney is a clinical-stage cell therapy company that develops proprietary, pharmaceutical grade, hydrogel-based formulations of umbilical cord Mesenchymal Stromal Cells (UC-MSCs) to treat advanced kidney disease and prevent its progression towards kidney failure. The company's products allow the continuous release of bioactive compounds from the UC-MSCs to the kidneys via unique routes of administration, triggering anti-inflammatory and anti-fibrotic effects through a systemic and local effect. Our pipeline of future products is based on our proprietary delivery platform and is designed to address a wide range of kidney-related diseases

List your booth number for exhibitions, ask us